(1)
Hind A. Alnajashi; Foziah Alshamrani,. Progressive Multifocal Leukoencephalopathy Risk Mitigation: A Focus on Approved Immunomodulatory Drugs for Multiple Sclerosis Treatment. JKAU Med Sci 2020, 27, 33-44.